Journal
JOURNAL OF NUCLEAR CARDIOLOGY
Volume 22, Issue 5, Pages 971-974Publisher
SPRINGER
DOI: 10.1007/s12350-015-0128-1
Keywords
-
Funding
- Mallinckrodt Pharma
- Siemens